CN102940853B - 一种治疗乳腺增生疾病的脐膏 - Google Patents
一种治疗乳腺增生疾病的脐膏 Download PDFInfo
- Publication number
- CN102940853B CN102940853B CN201210467306.9A CN201210467306A CN102940853B CN 102940853 B CN102940853 B CN 102940853B CN 201210467306 A CN201210467306 A CN 201210467306A CN 102940853 B CN102940853 B CN 102940853B
- Authority
- CN
- China
- Prior art keywords
- radix
- grams
- medicines
- paste
- cream
- Prior art date
Links
- 206010020718 Hyperplasia Diseases 0.000 title claims abstract description 15
- 210000004293 Mammary Glands, Human Anatomy 0.000 title claims abstract description 15
- 210000002264 Mammary Glands, Animal Anatomy 0.000 title abstract description 5
- 239000006072 pastes Substances 0.000 title abstract 7
- 239000003814 drugs Substances 0.000 claims abstract description 25
- 235000012907 honey Nutrition 0.000 claims abstract description 12
- 229940079593 drugs Drugs 0.000 claims abstract description 10
- 239000004863 Frankincense Substances 0.000 claims abstract description 5
- 238000002360 preparation methods Methods 0.000 claims abstract description 5
- 210000001113 Umbilicus Anatomy 0.000 claims description 19
- 239000006071 creams Substances 0.000 claims description 16
- 210000000582 Semen Anatomy 0.000 claims description 7
- 239000009286 sanguis draxonis Substances 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000000203 mixtures Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 241000972155 Moschus Species 0.000 claims 4
- 208000002193 Pain Diseases 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004369 Blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 235000014375 Curcuma Nutrition 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 206010006272 Breast mass Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 231100000486 side effect Toxicity 0.000 abstract description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 3
- 229940116229 Borneol Drugs 0.000 abstract 3
- 229930006709 borneol Natural products 0.000 abstract 3
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000266855 Astragalus mongholicus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000002123 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000006859 Jasminum officinale Species 0.000 abstract 1
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 280000862701 Maxim companies 0.000 abstract 1
- 235000016247 Mentha requienii Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 241000208966 Polygala Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 230000003213 activating Effects 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000006682 bigleaf mint Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 230000002708 enhancing Effects 0.000 abstract 1
- 235000006679 mint Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 210000000481 Breast Anatomy 0.000 description 25
- 244000153234 Hibiscus abelmoschus Species 0.000 description 13
- 241000545442 Radix Species 0.000 description 6
- 201000010099 diseases Diseases 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 230000001105 regulatory Effects 0.000 description 4
- 230000002522 swelling Effects 0.000 description 4
- 240000000772 Brassica cretica Species 0.000 description 3
- 235000003351 Brassica cretica Nutrition 0.000 description 3
- 235000003343 Brassica rupestris Nutrition 0.000 description 3
- 241000407170 Curcuma Species 0.000 description 3
- 244000111489 Gardenia augusta Species 0.000 description 3
- 235000014435 Mentha Nutrition 0.000 description 3
- 241001072983 Mentha Species 0.000 description 3
- 230000002146 bilateral Effects 0.000 description 3
- 235000010460 mustard Nutrition 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 230000002269 spontaneous Effects 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 206010006298 Breast pain Diseases 0.000 description 2
- 208000006662 Mastodynia Diseases 0.000 description 2
- 210000001331 Nose Anatomy 0.000 description 2
- 210000000952 Spleen Anatomy 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 239000007789 gases Substances 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 206010006223 Breast discharge Diseases 0.000 description 1
- 210000004907 Glands Anatomy 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 280000412365 I Level companies 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 206010027327 Menstrual diseases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000002445 Nipples Anatomy 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 231100000614 Poisons Toxicity 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000282941 Rangifer tarandus Species 0.000 description 1
- 208000009146 Rhinoscleroma Diseases 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 238000003379 elimination reactions Methods 0.000 description 1
- 239000000686 essences Substances 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agents Substances 0.000 description 1
- 239000005556 hormones Substances 0.000 description 1
- 230000002757 inflammatory Effects 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 231100000957 no side effects Toxicity 0.000 description 1
- 239000002674 ointments Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002062 proliferating Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 239000003440 toxic substances Substances 0.000 description 1
Abstract
本发明公开一种治疗乳腺增生疾病的脐膏，由制远志、当归、莪术、乳香、香附、白芷、荆芥穗、木香、薄荷、栀子、瓜蒌、黄芪、郁金、桃仁、丹参、血竭、冰片、人工麝香制成，上述诸药除麝香、冰片外，均研成80~150目细面，蜜调后加入研细的麝香、冰片，混匀于蜜调后膏内，做成每贴5~8克的外用脐膏。本发明针对乳腺增生的病因病机，其治病方案的指导思想应从活血化瘀，软坚散结，祛瘀消肿，散结止痛为主；所选药物均为天然植物药物，具有消除乳腺肿块、增强抵抗力，且疗效确切，见效快，无毒副作用，经临床验证治愈率较高。用药合理，配伍科学。
Description
一种治疗乳腺增生疾病的脐膏
技术领域
[0001] 本发明公开一种治疗乳腺增生疾病的脐膏，全部选用天然中草药制成，通过敷贴于患者的神闕穴(肚脐处)治疗乳腺增生疾病，属于中医制药技术领域。
背景技术
[0002] 乳腺增生病又称乳腺囊性增生，一类常见病、多发病，是以乳房周期性疼痛，乳房肿块为临床特点。现代医学认为此病是乳腺实质和间质的非炎性和非肿瘤性增生性病变，属中医“乳癖”、“乳痞”等范畴，多由于肝气郁结，痰凝血瘀，冲任失调所致。目前治疗乳腺病的西药很多，虽然具有一定疗效，但无法彻底根治，而且西医治疗乳腺增生常用的激素类药物对人体有副作用，现有的中药制剂在治疗乳腺增生方面有一定效果，但疗效并不明显。
发明内容
[0003] 本发明的目的在于克服现有治疗的不足，而提供一种治疗乳腺增生疾病的脐膏，全部选用天然中草药，能够显著提高乳腺增生的治疗效果。
[0004] 本发明提供的治疗乳腺增生疾病的脐膏，其特征是由下述重量的原料药制成:
[0005] 制远志30~35、当归30~35、莪术30~35、乳香15~20、香附15~20、白芷15~20、荆芥穗15~20、木香18~25、薄荷18~25、桅子18~25、瓜萎18~25、黄芪18~25、郁金18~25、桃仁15~20、丹参20~25、血竭5~10、冰片12~15、人工麝香5~8。
[0006] 本发明公开的治疗乳腺增生疾病的脐膏，其优选配比为:
[0007] 制远志30、当归`30、莪术30、乳香15、香附15、白芷15、荆芥穗15、木香18、薄荷18、桅子18、瓜萎18、黄芪18、郁金18、桃仁15、丹参20、血竭5、冰片12、人工麝香5。
[0008] 本发明提供的治疗乳腺增生疾病的脐膏的制备方法，可按常规的中药膏剂制备方法制备:
[0009] 上述诸药除麝香、冰片外，均研成80-150目细面，蜜调后加入研细的麝香、冰片，混匀于蜜调后膏内，做成每贴51克的外用脐膏。
[0010] 用法用量:每贴51克；贴敷于脐孔内(神闕穴)后用手指多按数下，直通脏腑病位，每3天换药一次。
[0011] 功能主治:乳腺囊性增生、乳房包块、囊性纤维瘤。
[0012] 功用:理气化瘀，软坚散结，清热解毒。
[0013] 本发明组方药物配伍中发挥以下功效:疏肝解郁，理气开郁，气行郁解，活血理气止痛，补气健脾，破血消於，软坚散结，消痰散结，宽胸理气，通达血脉，和中化痰，行气止痛，柔肝止痛，补气健脾，培后天之本，使气畅痛止结消，直达病所，诸药相伍，相得益彰，共凑疏肝理气，散结止痛之效，使郁结散，肿痛消，诸症自愈。
[0014] 本发明对临床治疗的200余例患者进行统计，治疗有效率达100%，治愈率93%。
[0015] 诊断标准根据临床症状分三级:
[0016] I级:乳房压痛，质软有正常腺体，肿块分布范围仅限1-2个乳房象限，最大直径1-2厘米。
[0017] II级:乳房自发性疼痛，以经前为主，质韧如鼻，肿块分布范围达3-4个乳房象限肿块最大直径2-4厘米。
[0018] III级:乳房自发痛呈持续性，放射到胁下，肩背，质硬如额，肿块片状直径5-6厘米，影响正常工作生活，伴月经失调，情绪烦躁，胁胀痛。有时有乳头溢液。
[0019] 疗效标准:
[0020] 有效:肿块消失，其余症状尚存。
[0021] 治愈:疼痛消失，肿块消失，伴随症状消失。
[0022] 无效:疼痛及肿块无明显改善。
[0023] 本发明的积极效果在于:针对乳腺增生的病因病机，其治病方案的指导思想应从活血化瘀，软坚散结，祛瘀消肿，散结止痛为主；所选药物均为天然植物药物，具有消除乳腺肿块、增强抵抗力，且疗效确切，见效快，无毒副作用，经临床验证治愈率较高。用药合理，配伍科学。
具体实施方式
[0024] 实施例1
[0025] 称取制远志30克、当归30克、莪术30克、乳香15克、香附15克、白芷15克、芥穗15克、木香18克、薄荷18克 、桅子18克、瓜萎18克、黄芪18克、郁金18克、桃仁15克、丹参20克、血竭5克、冰片12克、人工麝香5克，除麝香、冰片外，均研成100目细面，蜜调后加入研细的麝香、冰片，混匀于蜜调后膏内，做成每贴51克的脐贴。
[0026] 实施例2
[0027] 称取制远志35克、当归30克、莪术35克、乳香15克、香附20克、白芷20克、芥穗15克、木香25克、薄荷25克、桅子18克、瓜萎18克、黄芪25克、郁金18克、桃仁15克、丹参20克、血竭8克、冰片15克、人工麝香6克，除麝香、冰片外，均研成100目细面，蜜调后加入研细的麝香、冰片，混匀于蜜调后膏内，做成每贴51克的脐贴。
[0028] 实施例3
[0029] 称取制远志30克、当归35克、莪术35克、乳香20克、香附20克、白芷15克、芥穗20克、木香20克、薄荷20克、桅子20克、瓜萎20克、黄芪20克、郁金20克、桃仁20克、丹参25克、血竭10克、冰片15克、人工麝香8克，除麝香、冰片外，均研成100目细面，蜜调后加入研细的麝香、冰片，混匀于蜜调后膏内，做成每贴51克的脐贴。
[0030] 通过以下典型病例进一步表明本发明药物的治疗效果:
[0031]病例 I
[0032] 余某，女，35岁。患者于两年前开始经期左、右两侧乳房胀痛，两侧乳房内均可触及硬结，偶有刺疼，经期疼痛加重，体检:双乳外象限分别触及片状增厚，压痛，大小约3-5厘米与周围组织无粘连。B超检查示:双侧乳腺小叶增生。
[0033] 治疗:将本发明药物脐贴敷于脐孔内(神闕穴)后用手指多按数下，直通脏腑病位，每3天换药一次。2周见效，连续用药一月来院复查，结果:乳房柔软，疼痛消失，片状增厚消失，乳头发痒发痛消失，情绪稳定，复查B超未见明显异常。
[0034]病例 2[0035] 李某，女，38岁。两年来经前乳房疼痛，近日发现左侧乳房有个肿块，去医院检查诊断为乳腺增生。
[0036] 治疗:将本发明药物脐贴敷于脐孔内(神闕穴)后用手指多按数下，直通脏腑病位，每3天换药一次，2周见效，继续用药3个月后，症状全无，乳房肿炔基本消失。
[0037]病例 3
[0038] 章某，女士，32岁。妇科检查时查出左乳有包块，边界不清，压痛明显。诊断为乳腺增生。
[0039] 治疗:将本发明药物脐贴敷于脐孔内(神闕穴)后用手指多按数下，直通脏腑病位，每3天换药一次，治疗一个月后，左乳肿块变小，继续用药3个月，B超检查肿块消失，I年内随访未复发。
[0040]病例 4
[0041] 马某，女，48岁，诉其近月来失眠多梦，心烦口苦，急躁易怒，每至心情高兴时乳痛减轻，反之加重，并自检出乳房包快，压痛。初诊见:乳房似肿胀，坚硬如鼻尖，外观形态正常，触及乳房各个象限均有硬块，质韧，无边界，触痛，并向双侧腋下放射。行B超检查示:双侧乳腺小叶增生。
[0042] 治疗:将本发明药物脐贴敷于脐孔内(神闕穴)后用手指多按数下，直通脏腑病位，每3天换药一次，治疗一个月后，左乳肿块变小，继续用药3个月，B超检查肿块消失，半年后复诊见:乳房柔软，未及结块`，疼痛消失，情绪稳定，B超检查未见明显异常。
Claims (3)
1.一种治疗乳腺增生疾病的脐膏，其特征是由下述重量的原料药制成: 制远志30~35、当归30~35、莪术30~35、乳香15~20、香附15~20、白芷15~20、荆芥穗15~20、木香18~25、薄荷18~25、桅子18~25、瓜萎18~25、黄芪18~25、郁金18~25、桃仁15~20、丹参20~25、血竭5~10、冰片12~15、人工麝香5~8。
2.根据权利要求1所述的治疗乳腺增生疾病的脐膏，其特征是由下述重量的原料药制成: 制远志30、当归30、莪术30、乳香15、香附15、白芷15、荆芥穗15、木香18、薄荷18、桅子18、瓜萎18、黄芪18、郁金18、桃仁15、丹参20、血竭5、冰片12、人工麝香5。
3.制备权利 要求1或2所述的治疗乳腺增生疾病的脐膏的方法，包括以下步骤: 上述诸药除人工麝香、冰片外，均研成80-150目细面，蜜调后加入研细的人工麝香、冰片，混匀于蜜调后膏内，做成每贴51克的外用脐膏。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210467306.9A CN102940853B (zh) | 2012-11-19 | 2012-11-19 | 一种治疗乳腺增生疾病的脐膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210467306.9A CN102940853B (zh) | 2012-11-19 | 2012-11-19 | 一种治疗乳腺增生疾病的脐膏 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102940853A CN102940853A (zh) | 2013-02-27 |
| CN102940853B true CN102940853B (zh) | 2014-06-18 |
Family
ID=47723913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210467306.9A CN102940853B (zh) | 2012-11-19 | 2012-11-19 | 一种治疗乳腺增生疾病的脐膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940853B (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768532A (zh) * | 2014-02-17 | 2014-05-07 | 张梅 | 用于消除乳房肿胀的中药组合物 |
| CN103816522A (zh) * | 2014-03-11 | 2014-05-28 | 王江军 | 治疗乳腺增生的中药 |
| CN105381246A (zh) * | 2015-12-18 | 2016-03-09 | 青岛市第三人民医院 | 一种治疗乳房肿块的药艾条 |
| CN105363011A (zh) * | 2015-12-18 | 2016-03-02 | 青岛市第三人民医院 | 一种治疗气滞痰凝型乳房肿块的药艾条 |
| CN107773644A (zh) * | 2016-08-26 | 2018-03-09 | 柳莉娟 | 一种治疗乳腺增生及乳腺纤维瘤的外用中药丸 |
| CN107551106A (zh) * | 2017-08-15 | 2018-01-09 | 河南奕运医药科技有限公司 | 一种用于治疗乳腺结节、肿块疼痛的外用药剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1459309A (zh) * | 2002-05-21 | 2003-12-03 | 薛海川 | 乳腺增生一贴消 |
| CN102552818A (zh) * | 2012-02-15 | 2012-07-11 | 李新民 | 治疗乳腺疾病的外用药物组合物及其制备方法 |
-
2012
- 2012-11-19 CN CN201210467306.9A patent/CN102940853B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102940853A (zh) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102727832B (zh) | 一种治疗乳腺疾病和子宫肌瘤的中药制剂及其制备方法 | |
| CN102309644B (zh) | 一种治疗骨伤的中药组合物 | |
| CN102151325B (zh) | 一种治疗乳腺疾病的中药 | |
| CN1302801C (zh) | 治疗子宫肌瘤的中药复方制剂 | |
| CN1061854C (zh) | 治疗、预防妇科疾患的药物制剂 | |
| CN102961729A (zh) | 一种治疗静脉曲张、血栓闭塞性脉管炎及静脉炎的外用中药 | |
| CN101537168B (zh) | 一种治疗颈椎病及骨关节疾病的中药组合物及其制备方法 | |
| CN102091295B (zh) | 一种治疗股骨头坏死的中药组合物及其制备方法 | |
| CN103341064B (zh) | 一种治疗癃闭的中药组合物 | |
| CN101391077B (zh) | 一种治疗慢性盆腔炎的中药制备方法 | |
| CN104547790A (zh) | 一种治疗风湿性关节炎的中药组合物及其制备方法 | |
| CN101411848B (zh) | 一种治疗乳腺增生的黑膏药及其制备方法 | |
| CN101890104B (zh) | 一种治疗颈肩腰腿疼病的中药 | |
| CN101966320A (zh) | 一种治疗乳腺增生的中药组合物及其制备方法 | |
| CN101766789B (zh) | 一种治疗阑尾炎的中药组合物及其制备方法 | |
| CN102228603B (zh) | 一种治疗尿潴留的中药 | |
| CN102247581B (zh) | 一种治疗子宫肌瘤的药物 | |
| CN103055130A (zh) | 治疗慢性咽炎的中药组合物及其制备方法 | |
| CN103316174B (zh) | 一种治疗急性胆囊炎的中药组合物及其制备方法 | |
| CN103071128B (zh) | 一种治疗痛经的外用贴膏 | |
| CN102908603B (zh) | 一种治疗乳腺增生的中药 | |
| CN103599494A (zh) | 一种治疗颈椎病的外用中药 | |
| CN102895460B (zh) | 一种用于骨折、软组织损伤的中药组合物 | |
| CN103933468A (zh) | 一种用于治疗急性胰腺炎的中药 | |
| CN101810835A (zh) | 一种治疗紫癜的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| C14 | Grant of patent or utility model | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140618 Termination date: 20141119 |
|
| EXPY | Termination of patent right or utility model |